November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering from ...
November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...
November 14, 2019 — A new study from researchers at the Smidt Heart Institute at Cedars-Sinai shows that electronic ...
November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...
November 14, 2019 — A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...
November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...
This is a photo essay of new technologies and activities at the American Society of Nuclear Cardiology (ASNC) 2019 ...
November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...
November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...
November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...
November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...
November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...
Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...
Piotr J. Slomka, Ph.D., FACC, research scientist in the Artificial Intelligence in Medicine Program, Department of ...
November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...